Report of Foreign Issuer (6-k)
March 22 2018 - 07:08AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month
of March, 2018
Commission
File Number: 001-37891
AC IMMUNE
SA
(Exact
name of registrant as specified in its charter)
EPFL Innovation
Park
Building
B
1015 Lausanne,
Switzerland
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
AC IMMUNE SA
|
|
|
|
|
|
|
By:
|
/s/ Andrea Pfeifer
|
|
|
|
|
Name:
|
Andrea Pfeifer
|
|
|
|
|
Title:
|
Chief Executive Officer
|
|
|
|
By:
|
/s/ Joerg Hornstein
|
|
|
|
|
Name:
|
Joerg Hornstein
|
|
|
|
|
Title:
|
Chief Financial Officer
|
Date:
March 22, 2018
EXHIBIT
INDEX
Exhibit Number
|
Description
|
99.1
|
Invitation to the Extraordinary Shareholders’ Meeting
|
99.2
|
2018
Extraordinary Shareholders’ Meeting Proxy Card
|
99.3
|
Instructions
on How to Become a Holder of Record
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Feb 2024 to Mar 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2023 to Mar 2024